Beckman Coulter moves up to No 3 with $800m Olympus' diagnostics buy
This article was originally published in Clinica
Biomedical tests and labs systems manufacturer Beckman Coulter today announced that it will acquire the lab-based diagnostics business of Olympus' Life Sciences business for ¥77.45bn ($800m).
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
The RSNA is the next global medtech exhibition and conference event to be run under a virtual format this fall.